Search results: Sage Journals

Free accessCase reportFirst published July, 2017

Characterization of a Rare Nonpathogenic Sequence Variant (c.1905C>T) of the Dihydropyrimidine Dehydrogenase Gene ( DPYD )

Raffaele Palmirotta, Domenica Lovero, Erica Silvestris [...]

The International Journal of Biological Markers

Free accessResearch articleFirst published January, 2024

Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: Perspectives of medical oncologists and oncology pharmacists

Sarah Glewis, Senthil Lingaratnam, Mei Krishnasamy [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published January, 2023

Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with a DPYD variant and decreased dihydropyrimidine dehydrogenase enzyme activity

Charlotte W Ockeloen, Aron Raaijmakers, Manon Hijmans-van der Vegt [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published 2026

Pre-emptive DPYD genotyping and fluoropyrimidine dose optimisation: Dose tolerance and survival in cancer patients

Sarah Glewis, Senthil Lingaratnam, Tim Spelman [...]

Journal of Oncology Pharmacy Practice

Free accessResearch articleFirst published August, 2017

Hydrogel microarray for detection of polymorphisms in the UGT1A1,DPYD,GSTP1 and ABCB1 genes

Rustam Heydarov, Sergei Titov, Mikhail Abramov [...]

Cancer Biomarkers

Open accessResearch articleFirst published October, 2018

Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience

Con Murphy, Stephen Byrne, Gul Ahmed [...]

Dose-Response

Restricted accessResearch articleFirst published April, 2021

DPYD c.1905 + 1G>A Promotes Fluoropyrimidine-Induced Anemia,a Prognostic Factor in Disease-Free Survival,in Colorectal Cancer

Adem Deligonul, Secil Aksoy, Gulcin Tezcan [...]

Genetic Testing and Molecular Biomarkers

Open accessResearch articleFirst published June, 2017

Letter regarding Zhao et al. entitled “ DPYD gene polymorphisms are associated with risk and chemotherapy prognosis in pediatric patients with acute lymphoblastic leukemia”

Maarten J Deenen, Linda M Henricks, Gabe S Sonke [...]

Tumor Biology

Restricted accessResearch articleFirst published October, 2024

DPD deficiency in an Irish oncology centre: Prevalence and clinical implications

Ruth Kieran, Taylor Mitchell, Afrah Al Fazari [...]

Journal of Oncology Pharmacy Practice

Free accessResearch articleFirst published May, 2018

Deciphering the potential value of 5-fluorouracil metabolic enzymes in predicting prognosis and treatment response of colorectal cancer patients

Kinjal K. Gajjar, Hemangini H. Vora, Toral P. Kobawala [...]

The International Journal of Biological Markers

Free accessCase reportFirst published July, 2017

Characterization of a Rare Nonpathogenic Sequence Variant (c.1905C>T) of the Dihydropyrimidine Dehydrogenase Gene ( DPYD )

Raffaele Palmirotta, Domenica Lovero, Erica Silvestris [...]

The International Journal of Biological Markers

Free accessResearch articleFirst published January, 2024

Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: Perspectives of medical oncologists and oncology pharmacists

Sarah Glewis, Senthil Lingaratnam, Mei Krishnasamy [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published January, 2023

Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with a DPYD variant and decreased dihydropyrimidine dehydrogenase enzyme activity

Charlotte W Ockeloen, Aron Raaijmakers, Manon Hijmans-van der Vegt [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published 2026

Pre-emptive DPYD genotyping and fluoropyrimidine dose optimisation: Dose tolerance and survival in cancer patients

Sarah Glewis, Senthil Lingaratnam, Tim Spelman [...]

Journal of Oncology Pharmacy Practice

Free accessResearch articleFirst published August, 2017

Hydrogel microarray for detection of polymorphisms in the UGT1A1,DPYD,GSTP1 and ABCB1 genes

Rustam Heydarov, Sergei Titov, Mikhail Abramov [...]

Cancer Biomarkers

Open accessResearch articleFirst published October, 2018

Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience

Con Murphy, Stephen Byrne, Gul Ahmed [...]

Dose-Response

Restricted accessResearch articleFirst published April, 2021

DPYD c.1905 + 1G>A Promotes Fluoropyrimidine-Induced Anemia,a Prognostic Factor in Disease-Free Survival,in Colorectal Cancer

Adem Deligonul, Secil Aksoy, Gulcin Tezcan [...]

Genetic Testing and Molecular Biomarkers

Open accessResearch articleFirst published June, 2017

Letter regarding Zhao et al. entitled “ DPYD gene polymorphisms are associated with risk and chemotherapy prognosis in pediatric patients with acute lymphoblastic leukemia”

Maarten J Deenen, Linda M Henricks, Gabe S Sonke [...]

Tumor Biology

Restricted accessResearch articleFirst published October, 2024

DPD deficiency in an Irish oncology centre: Prevalence and clinical implications

Ruth Kieran, Taylor Mitchell, Afrah Al Fazari [...]

Journal of Oncology Pharmacy Practice

Free accessResearch articleFirst published May, 2018

Deciphering the potential value of 5-fluorouracil metabolic enzymes in predicting prognosis and treatment response of colorectal cancer patients

Kinjal K. Gajjar, Hemangini H. Vora, Toral P. Kobawala [...]

The International Journal of Biological Markers